Home/Filings/4/0001062993-25-003231
4//SEC Filing

Montecalvo Antonio S. 4

Accession 0001062993-25-003231

CIK 0001661181other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 5:53 PM ET

Size

7.2 KB

Accession

0001062993-25-003231

Insider Transaction Report

Form 4
Period: 2025-02-19
Montecalvo Antonio S.
Vice President, Health Policy
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-19+43,95643,956 total
    Exercise: $3.53Exp: 2035-02-19Class A Common Stock (43,956 underlying)
  • Award

    Class A Common Stock

    2025-02-19+42,493196,680 total
Footnotes (2)
  • [F1]Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2025.
  • [F2]The option becomes exercisable in equal annual installments over four years beginning February 15, 2025.

Issuer

Organogenesis Holdings Inc.

CIK 0001661181

Entity typeother

Related Parties

1
  • filerCIK 0001759261

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 5:53 PM ET
Size
7.2 KB